These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16309521)

  • 21. [The current concepts of acute toxic-allergic drug reactions and their treatment aspects].
    Latysheva TV; Gushchin IS; Poroshina IuA
    Ter Arkh; 1991; 63(10):25-37. PubMed ID: 1839582
    [No Abstract]   [Full Text] [Related]  

  • 22. [Toxidermia due to noramidopyrine (Avafortan)].
    Thivolet J; Perrot H; Tambourgi A; Pellerat J; Claudy A
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(2):192-3. PubMed ID: 4256850
    [No Abstract]   [Full Text] [Related]  

  • 23. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discoloured tongue: a new cause?
    Scully C
    Br J Dermatol; 2001 Jun; 144(6):1293-4. PubMed ID: 11422078
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic criteria for cutaneous adverse drug reactions].
    Aihara M
    Arerugi; 2012 Aug; 61(8):1061-6. PubMed ID: 23089970
    [No Abstract]   [Full Text] [Related]  

  • 26. [Toxidermia].
    Basset A; Maleville J; Bergoend H; Grosshans E; Heid E; Zimmer J
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(5):690-6. PubMed ID: 4253110
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allergic dermatoses. 6. Bullous allergic exanthemas].
    Marghescu S
    Fortschr Med; 1984 Aug; 102(31-32):799-801. PubMed ID: 6237041
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of lansoprazole.
    Colin-Jones DG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():56-60, discussion 61-6. PubMed ID: 8490081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible lansoprazole-induced eosinophilic syndrome.
    Smith JD; Chang KL; Gums JG
    Ann Pharmacother; 1998 Feb; 32(2):196-200. PubMed ID: 9496405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bullous lesions and necrosis of the sudoriparous glands in acute drug poisoning].
    Laplante L; Barcelo R; Carrière S; Legresley LP; Beaudry C
    Union Med Can; 1971 Sep; 100(9):1755-61. PubMed ID: 4255803
    [No Abstract]   [Full Text] [Related]  

  • 32. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug eruptions in children.
    Shin HT; Chang MW
    Curr Probl Pediatr; 2001 Aug; 31(7):207-34. PubMed ID: 11500668
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bullous toxicoderma].
    Belaich S; Degos R
    Rev Prat; 1975 Dec; 25(57):4525-34. PubMed ID: 129849
    [No Abstract]   [Full Text] [Related]  

  • 35. [Recent findings on the side effects of drugs on the skin].
    Marghescu S
    Internist (Berl); 1983 Jun; 24(6):329-33. PubMed ID: 6223897
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical manifestations of dermatitis medicamentosa].
    Davatdarova MM
    Vestn Dermatol Venerol; 1983 Jan; (1):42-6. PubMed ID: 6219509
    [No Abstract]   [Full Text] [Related]  

  • 37. Omeprazole-induced dermatomyositis.
    Pan Y; Chong AH; Williams RA; Green J; Sinclair R
    Br J Dermatol; 2006 Mar; 154(3):557-8. PubMed ID: 16445794
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complications of drug therapy].
    Lebedeva GV; Kriukova OI; Zelenina OI; Gess LV; Alekseeva IA
    Vestn Dermatol Venerol; 1983 May; (5):44-7. PubMed ID: 6224363
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.